-
Inducing Labor in Denmark: A Descriptive Study
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization in Adults with Type 1 Diabetes Who Have a Prior Type 2 Diabetes Misdiagnosis and Recorded HbA1c in a US Managed Care Population
Sep 9, 2025, 16:22 PM -
Viable Reimbursement and Financing Models for mHealth Interventions in Sub-Saharan Africa: A Narrative Review
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Time Burden in Patients With Myelodysplastic Syndromes/Neoplasms Initiating Oral Decitabine and Cedazuridine or Intravenous/Subcutaneous Hypomethylating Agents
Sep 9, 2025, 16:22 PM -
The Soft Science in Hard Decisions: Utility of Qualitative Evidence in HTA Decisions
Sep 9, 2025, 16:22 PM -
Scaling Responsible Healthcare Data Access With AI-Driven Sensitive Patient Variable Detection
Sep 9, 2025, 16:22 PM -
The Incidence and Survival of HPV-Positive and HPV-Negative Malignant Head and Neck Squamous Cell Carcinoma (HNSCC) in the United States: A Surveillance Epidemiology and End Results SEER 2000-2022 Database Analysis
Sep 9, 2025, 16:22 PM -
Impacts of National Medical Insurance Negotiation on Antitumor Drug Utilization and Financial Burden: A City-Level Analysis in China
Sep 9, 2025, 16:22 PM -
Variability in Health Utility Scores in Pancreatic Cancer: Findings From a Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Economic Burden Utilities and Cost-Effectiveness of Perioperative Immunotherapies for Early Stage Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
A Patient-Level Simulation to Bridge Data Gaps in Cost-Effectiveness Modeling of B-VEC for Dystrophic Epidermolysis Bullosa
Sep 9, 2025, 16:22 PM -
Proportion of the Expenses of Over-the-Counter Equivalent Drugs Among Total Healthcare an Analysis Using the Wellness-Star☆ Database
Sep 9, 2025, 16:22 PM -
Statistical Analysis of Health Technology Assessment Outcomes in Oncology: An Analysis of Key Clinical Value Drivers in Germany and France
Sep 9, 2025, 16:22 PM -
An Exploration of the Incidence Rate of Anxiety and Depression Following a Diagnosis of Rheumatoid Arthritis Using the THIN Dataset
Sep 9, 2025, 16:22 PM -
Evolution of Manufacturer-Set List Prices and GKV Rebates for Orphan Drugs (OD) in Germany 2013-2024: How Much US WAC Is in German OD-Prices
Sep 9, 2025, 16:22 PM -
Population-Level Impact of Emicizumab in Algeria: A 25-Year Projection
Sep 9, 2025, 16:22 PM -
Simulating Patient Journeys in Heart Failure to Optimize Treatment Pathways: An Agent-Based Modeling Study
Sep 9, 2025, 16:22 PM -
Stakeholder Engagement in the Economic Evaluation of Site-Specific Wastewater-Based Surveillance for Preventing COVID-19 Outbreaks in Long-Term Care Facilities
Sep 9, 2025, 16:22 PM -
Value of Patient-Reported Outcomes Data in Food and Drug Administration Labeling of Oncology Drugs to Payers in the United States
Sep 9, 2025, 16:22 PM -
Development and Validation of an Automated Cancer Stage Classifier for Real-World Oncology Data Mapped to the OMOP Common Data Model
Sep 9, 2025, 16:22 PM
